Quality of life issues during adjuvant endocrine therapy.
Fallowfield
Lesley
L
University of Sussex, BN1 9QG, East Sussex, UK. l.j.fallowfield@sussex.ac.uk
Jenkins
Valerie
V
D047072:Aromatase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000523:psychology*; D005260:Female; D006801:Humans; D055118:Medication Adherence; D010342:Patient Acceptance of Health Care; D017697:Premenopause; D011788:Quality of Life; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*
D047072:Aromatase Inhibitors; D013629:Tamoxifen